2023 - Research.com Neuroscience in Germany Leader Award
Stefan J. Teipel mainly focuses on Alzheimer's disease, Pathology, Neuroscience, Atrophy and Dementia. His Alzheimer's disease study combines topics from a wide range of disciplines, such as Magnetic resonance imaging and Central nervous system disease, Degenerative disease. The various areas that Stefan J. Teipel examines in his Pathology study include Hippocampus and Grey matter.
His Neuroscience research includes themes of Hyperintensity, Position paper and Disease. His Atrophy research incorporates themes from Down syndrome and Basal ganglia. His studies in Dementia integrate themes in fields like Voxel, Voxel-based morphometry, Neuroimaging and Feature.
Stefan J. Teipel mainly investigates Neuroscience, Dementia, Disease, Pathology and Internal medicine. As part of the same scientific family, Stefan J. Teipel usually focuses on Neuroscience, concentrating on Atrophy and intersecting with Basal forebrain. His study on Dementia also encompasses disciplines like
While the research belongs to areas of Pathology, Stefan J. Teipel spends his time largely on the problem of White matter, intersecting his research to questions surrounding Diffusion MRI. His work deals with themes such as Endocrinology and Oncology, which intersect with Internal medicine. Stefan J. Teipel has researched Alzheimer's disease in several fields, including Cerebrospinal fluid and Central nervous system disease, Degenerative disease.
Stefan J. Teipel focuses on Dementia, Cognitive decline, Internal medicine, Disease and Neuroscience. He interconnects Audiology, Cognition, Effects of sleep deprivation on cognitive performance, Basal forebrain and Memory clinic in the investigation of issues within Cognitive decline. The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine.
His Disease research is multidisciplinary, incorporating perspectives in Hippocampal formation, Magnetic resonance imaging, Cerebrospinal fluid and Clinical psychology. His Neuroscience research focuses on In vivo and how it connects with Parkinson's disease. His research integrates issues of Alzheimer's disease and Hippocampus in his study of Cohort.
His primary scientific interests are in Dementia, Internal medicine, Cognitive decline, Disease and Randomized controlled trial. He combines subjects such as Stimulus, Neuroplasticity, Prefrontal cortex and Cognitive impairment with his study of Dementia. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
The Cognitive decline study combines topics in areas such as Mild cognitive impairment, Categorization and Neurology, Neuroimaging, Neuroscience. His Neuroscience research includes elements of Alpha and Rhythm. His study looks at the relationship between Disease and fields such as Cerebrospinal fluid, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Joanna M. Wardlaw;Eric E. Smith;Geert J Biessels;Charlotte Cordonnier.
Lancet Neurology (2013)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger;Michael Ewers;Tuula Pirttila;Raymond Zinkowski.
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease*
Harald Hampel;Harald Hampel;Katharina Bürger;Stefan J. Teipel;Arun L.W. Bokde;Arun L.W. Bokde.
Alzheimers & Dementia (2008)
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Harald Hampel;Katharina Buerger;Raymond Zinkowski;Stefan J. Teipel.
Archives of General Psychiatry (2004)
Focal Decline of Cortical Thickness in Alzheimer's Disease Identified by Computational Neuroanatomy
Jason P. Lerch;Jens C. Pruessner;Alex Zijdenbos;Harald Hampel.
Cerebral Cortex (2005)
Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease
R C Dodel;Y Du;C Depboylu;H Hampel.
Journal of Neurology, Neurosurgery, and Psychiatry (2004)
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
H. Hampel;S. J. Teipel;T. Fuchsberger;N. Andreasen.
Molecular Psychiatry (2004)
Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls.
Jason P. Lerch;Jens Pruessner;Jens Pruessner;Alex P. Zijdenbos;D. Louis Collins.
Neurobiology of Aging (2008)
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease.
Claudia Plant;Stefan J. Teipel;Stefan J. Teipel;Annahita Oswald;Christian Böhm.
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Katharina Buerger;Raymond Zinkowski;Stefan J. Teipel;Tero Tapiola.
JAMA Neurology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: